HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patrizia Vici Selected Research

Male Breast Neoplasms (Male Breast Cancer)

10/2016HMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomes.
11/2015Androgen receptor and antiandrogen therapy in male breast cancer.
5/2015Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis.
3/2015Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective study.
11/2014Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series.
9/2014Aromatase inhibitors for metastatic male breast cancer: molecular, endocrine, and clinical considerations.
8/2013Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patrizia Vici Research Topics

Disease

87Breast Neoplasms (Breast Cancer)
06/2022 - 06/2002
58Neoplasms (Cancer)
06/2022 - 06/2002
11Neoplasm Metastasis (Metastasis)
11/2021 - 08/2011
11Triple Negative Breast Neoplasms
01/2021 - 01/2015
9Ovarian Neoplasms (Ovarian Cancer)
01/2020 - 08/2013
7Male Breast Neoplasms (Male Breast Cancer)
10/2016 - 08/2013
6Uterine Cervical Neoplasms (Cancer of the Cervix)
04/2021 - 01/2014
6Disease Progression
12/2020 - 08/2013
4Carcinoma (Carcinomatosis)
04/2020 - 02/2008
4Stomach Neoplasms (Stomach Cancer)
01/2018 - 09/2013
4Ovarian Epithelial Carcinoma
01/2016 - 08/2013
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2020 - 01/2019
2Adenocarcinoma of Lung
12/2021 - 11/2019
2Obesity
11/2020 - 10/2016
2Pathologic Complete Response
09/2020 - 01/2020
2COVID-19
08/2020 - 01/2020
2Colonic Neoplasms (Colon Cancer)
04/2020 - 01/2019
2Brain Neoplasms (Brain Tumor)
04/2020 - 01/2019
2Head and Neck Neoplasms (Head and Neck Cancer)
04/2020 - 01/2017
2Ataxia Telangiectasia (Louis Bar Syndrome)
11/2019 - 01/2019
2Cardiotoxicity
01/2019 - 01/2014
2Rare Diseases (Rare Disease)
08/2017 - 11/2014
2Residual Neoplasm
12/2015 - 06/2002
1Prostatic Neoplasms (Prostate Cancer)
07/2022
1Vulvar Neoplasms (Vulvar Cancer)
08/2021

Drug/Important Bio-Agent (IBA)

23Hormones (Hormone)IBA
06/2022 - 02/2008
16Trastuzumab (Herceptin)FDA Link
11/2021 - 04/2013
15AnthracyclinesIBA
09/2020 - 06/2002
12Biomarkers (Surrogate Marker)IBA
07/2021 - 02/2004
10EverolimusFDA Link
06/2022 - 01/2016
10Phenobarbital (Luminal)FDA Link
06/2022 - 10/2014
9Immune Checkpoint InhibitorsIBA
12/2021 - 11/2017
8Estrogen ReceptorsIBA
01/2021 - 10/2014
8exemestane (Aromasin)FDA Link
12/2020 - 01/2017
8Taxoids (Taxanes)IBA
09/2020 - 03/2008
8Epirubicin (Ellence)FDA LinkGeneric
04/2011 - 03/2002
7human ERBB2 proteinIBA
01/2021 - 10/2014
7pertuzumabIBA
01/2021 - 01/2015
7eribulinFDA Link
01/2021 - 01/2014
7Progesterone Receptors (Progesterone Receptor)IBA
01/2021 - 10/2014
6Biological ProductsIBA
08/2021 - 01/2014
6Aromatase InhibitorsIBA
02/2020 - 08/2011
6Bevacizumab (Avastin)FDA Link
01/2019 - 01/2016
6Docetaxel (Taxotere)FDA Link
10/2014 - 04/2004
6Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2011 - 06/2002
5Fulvestrant (Faslodex)FDA Link
11/2021 - 08/2017
5Pharmaceutical PreparationsIBA
01/2021 - 02/2008
5PlatinumIBA
04/2020 - 08/2013
5Capecitabine (Xeloda)FDA Link
09/2019 - 04/2013
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 01/2014
5Glucose (Dextrose)FDA LinkGeneric
02/2018 - 11/2014
5GemcitabineFDA Link
08/2013 - 04/2004
4Lapatinib (GW572016)FDA Link
06/2022 - 04/2013
4palbociclibIBA
06/2022 - 01/2019
4DNA (Deoxyribonucleic Acid)IBA
04/2021 - 12/2015
4Estrogens (Estrogen)FDA Link
01/2021 - 01/2013
4Phosphotransferases (Kinase)IBA
11/2019 - 01/2016
4Monoclonal AntibodiesIBA
01/2019 - 01/2016
4Gonadotropin-Releasing Hormone (GnRH)FDA Link
05/2015 - 08/2013
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2014 - 09/2003
4Vinorelbine (Navelbine)FDA LinkGeneric
04/2011 - 06/2002
3Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2021 - 09/2017
3Ado-Trastuzumab EmtansineIBA
01/2021 - 01/2017
3Indicators and Reagents (Reagents)IBA
11/2020 - 01/2015
3VaccinesIBA
10/2020 - 03/2014
3TamoxifenFDA LinkGeneric
01/2019 - 02/2008
3ErbB Receptors (EGF Receptor)IBA
01/2019 - 04/2013
3Antineoplastic Agents (Antineoplastics)IBA
01/2019 - 02/2015
3Paclitaxel (Taxol)FDA LinkGeneric
01/2018 - 03/2011
3Androgen Antagonists (Antiandrogens)IBA
11/2015 - 11/2014
3lonidamineIBA
07/2006 - 09/2003
2ribociclibIBA
06/2022 - 01/2021
2AndrogensIBA
11/2021 - 11/2015
2Cyclin-Dependent Kinase 4IBA
01/2021 - 12/2020
2NivolumabIBA
04/2020 - 01/2019
2Proteins (Proteins, Gene)FDA Link
11/2019 - 01/2019
2Oncogene Proteins (Oncogene Protein)IBA
06/2016 - 01/2016
2Tyrosine Kinase InhibitorsIBA
01/2016 - 04/2013
2Metformin (Glucophage)FDA LinkGeneric
01/2016 - 05/2015
2Insulin (Novolin)FDA Link
01/2016 - 05/2015
2Androgen Receptors (Androgen Receptor)IBA
11/2015 - 11/2014
2Cyproterone AcetateIBA
05/2015 - 11/2014
2Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2014 - 08/2013
2Fertility AgentsIBA
01/2014 - 02/2013
2liposomal doxorubicin (Doxil)FDA Link
01/2014 - 04/2011
2Filgrastim (Neupogen)FDA Link
10/2005 - 01/2004
1GenieIBA
12/2021
1fluorocholineIBA
11/2021
1abemaciclibIBA
01/2021
1talazoparibIBA
01/2021
1olaparibIBA
01/2021
1GlucocorticoidsIBA
01/2021
1Poly Adenosine Diphosphate RiboseIBA
01/2021

Therapy/Procedure

52Therapeutics
06/2022 - 02/2004
37Drug Therapy (Chemotherapy)
06/2022 - 06/2002
16Neoadjuvant Therapy
01/2021 - 06/2002
7Immunotherapy
01/2022 - 03/2014
3Radiotherapy
07/2022 - 10/2020
2Combination Drug Therapy (Combination Chemotherapy)
03/2015 - 10/2014
1Drug Tapering
01/2021